BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nijevitch AA, Idrisov B, Akhmadeeva EN, Graham DY. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des 2014;20:4510-6. [PMID: 24180406 DOI: 10.2174/13816128113196660728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Muñoz AB, Stepanian J, Trespalacios AA, Vale FF. Bacteriophages of Helicobacter pylori. Front Microbiol 2020;11:549084. [PMID: 33281754 DOI: 10.3389/fmicb.2020.549084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Tsai CF, Chen MH, Wang YP, Liu PY, Hou MC, Lee FY, Lu CL. Increased risk of short-term depressive disorder after Helicobacter pylori eradication: A population-based nested cohort study. Helicobacter 2021;26:e12824. [PMID: 34117671 DOI: 10.1111/hel.12824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Talebi Bezmin Abadi A. Updated Helicobacter pylori management in 2015. Saudi J Gastroenterol 2016;22:80. [PMID: 26831613 DOI: 10.4103/1319-3767.173765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ram M. R, Teh X, Rajakumar T, Goh KL, Leow AHR, Poh BH, Mariappan V, Shankar EM, Loke MF, Vadivelu J. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy. Journal of Antimicrobial Chemotherapy 2019;74:11-6. [DOI: 10.1093/jac/dky401] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Jonaitis P, Kupcinskas J, Nyssen OP, Puig I, Gisbert JP, Jonaitis L. Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg). Medicina (Kaunas) 2021;57:642. [PMID: 34201428 DOI: 10.3390/medicina57070642] [Reference Citation Analysis]
6 Mousavi T, Nikfar S, Abdollahi M. The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opin Pharmacother 2021;:1-27. [PMID: 34435515 DOI: 10.1080/14656566.2021.1959914] [Reference Citation Analysis]